{
    "clinical_study": {
        "@rank": "102683", 
        "arm_group": [
            {
                "arm_group_label": "Minimal stimulation protocol", 
                "arm_group_type": "Active Comparator", 
                "description": "Low dose Letrozole 2.5 mg over 5 days, starting from cycle day 2, overlapping with low dose gonadotropins, starting from day 3 of the Letrozole at 150 units per day. GnRH antagonist to avoid premature LH surge will be introduced when one or more of the growing follicles reached approximately 14 mm in size"
            }, 
            {
                "arm_group_label": "High dose protocol", 
                "arm_group_type": "Active Comparator", 
                "description": "High dose of gonadotropins (\u2265300 IU/day) starting from cycle day 3. GnRH antagonist will be introduced to avoid premature LH surge when one or more of the growing follicles will reach approximately 14 mm in size"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether minimal ovarian stimulation for in vitro\n      fertilization is superior to high dose stimulation. Number of mature eggs, number of embryos\n      as well as pregnancy rates will be compared."
        }, 
        "brief_title": "Comparison of 2 Ovarian Stimulation Protocols for Women With Low Ovarian Reserve", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "detailed_description": {
            "textblock": "A prospective randomized  trial will be carried out.  The Minimal stimulation (MS) protocol\n      is based on low dose letrozole 2.5 mg over 5 days, starting from cycle day 2, overlapping\n      with low dose gonadotropins, starting from day 3 of the letrozole at 150 units per day. GnRH\n      antagonist wil be introduced to avoid premature LH surge when one or more of the growing\n      follicles reached approximately 14 mm in size. The high dose stimulation protocol is based\n      on high dose of gonadotropins (\u2265300 IU/day) throughout the cycle with the usage of\n      gonadotropin-releasing hormone (GnRH) antagonist to avoid premature luteinizing hormone (LH)\n      surge as described above."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of poor responder to ovarian stimulation\n\n        Exclusion Criteria:\n\n          -  Patients undergoing pregestational diagnosis (PGD)\n\n          -  Patients using donor eggs"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "43 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02128360", 
            "org_study_id": "SHEBA-14-1034-SD-CTIL"
        }, 
        "intervention": [
            {
                "arm_group_label": "Minimal stimulation protocol", 
                "intervention_name": "Letrozole, Gonadotropins", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "High dose protocol", 
                "intervention_name": "Gonadotropins", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Letrozole"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Low ovarian reserve", 
            "Poor responder", 
            "Infertility"
        ], 
        "lastchanged_date": "April 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tel Hashomer", 
                    "country": "Israel", 
                    "zip": "52621"
                }, 
                "name": "The Chaim Sheba Medical Center"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Analysis of IVF Outcome After Minimal Stimulation vs. High Dose Stimulation for Patients With Low Ovarian Reserve", 
        "overall_contact": {
            "email": "dr.shirdar@gmail.com", 
            "last_name": "Shir Dar, MD"
        }, 
        "overall_official": {
            "affiliation": "Sheba Medical Center", 
            "last_name": "Shir Dar, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Clinical pregnancy rates", 
            "safety_issue": "No", 
            "time_frame": "1 Year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02128360"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "How many embryos of 6-8 cells with low fragmentation in each arm", 
                "measure": "Number of High quality embryos", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Number of eggs retrieved", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Sheba Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sheba Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}